Association between Helicobacter Pylori Infection and Graves’ Disease: A Meta-Analysis

Guntur Darmawan, Marcellus Simadibrata, Indah Suci Widyahening


Background & Aims: Helicobacter pylori (H. pylori) infection is proposed to be related with autoimmune diseases, such as Graves’ Disease (GD). This study aimed to assess the association between H. pylori infection and GD.


Methods: A systematic literature review was conducted using Pubmed and Cochrane library. The quality of enrolled studies was assessed by the Critical Appraisal Skills Program Oxford. A fixed-effect model approach was used if there was no heterogeneity; otherwise, a random-effect model was used. Heterogeneity was assessed using I2. Publication bias was assessed by funnel plot. All data were analyzed using REVIEW MANAGER 5.3.


Results: Six studies from Europe and Asia involving 983 patients were included. Overall H. pylori infection was significantly associated with GD (OR 2.7; 95% CI: 1.47-4.99; p < 0.001). In subgroup analysis of 3 studies using non-serological diagnostic method, the prevalence rate of H. pylori infection was higher in GD group (78.26% VS 42.42%) with significant relationship (OR 4.93; 95% CI: 3.16-7.69; p < 0.00001; I2 = 0%). The CagA antibody prevalence was significantly higher in GD group (46.57% VS 20.29%; OR 4.41; 95% CI: 2.65-7.33; p < 0.00001; I2 = 56%). No publication bias was observed.


Conclusion: Our study showed association between H. pylori infection and GD. It might suggest the need of H. pylori examination in GD patients and the impact of H. pylori eradication in the treatment of GD.


Helicobacter pylori, Graves’ disease, meta-analysis

Full Text:



Effraimidis G, Wiersinga WM. Mechanisms in endocrinology: Autoimmune thyroid disease: Old and new players. Eur J Endocrinol. 2014, 170(6):R241–52.

Prabhakar BS, Bahn RS, Smith TJ. Current perspective on the pathogenesis of Graves’ disease and ophthalmopathy. Endocr Rev. 2003, 24(6):802–35.

Smyk DS, Koutsoumpas AL, Mytilinaiou MG, Rigopoulou EI, Sakkas LI, Bogdanos DP. Helicobacter pylori and autoimmune disease: Cause or bystander. World J Gastroenterol. 2014, 20(3):613–29.

Franceschi F, Tortora A, Gasbarrini G, Gasbarrini A. Helicobacter pylori and extragastric diseases. Helicobacter. 2014, 19(1):52–8.

Hasni S, Ippolito A, Illei GG. Helicobacter pylori and autoimmune diseases. Oral Dis. 2013, 17(7):621–7.

Mayr M, Kiechl S, Mendall M a, Willeit J, Wick G, Xu Q. Increased risk of atherosclerosis is confined to CagA-positive Helicobacter pylori strains: Prospective results from the bruneck study. Stroke. 2003, 34(3):610–5.

Bassi V, Santinelli C, Iengo A, Romano C. Identification of a correlation between Helicobacter pylori infection and Graves ’ disease. Helicobacter. 2010, 15:558–62.

Wang Y, Zhu S, Xu Y, Wang X, Zhu Y. Interaction between gene A-positive Helicobacter pylori and human leukocyte antigen II alleles increase the risk of Graves disease in Chinese Han population: An association study. Gene. 2013, 531(1):84–9.

Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLoS Med. 2009, 6(6): e1000097.

Critical Appraisal Skill Program. Eleven questions to make you make sense of case control study [cited 2015 July]. Available from:

Cochrane Consumers and Communication Review Group. Heterogeneity and subroup analyses in Cochrane Consumers and Communication Review Group reviews: Planning the analysis at protocol stage [cited 2015 July]. Available from:

De Luis D, Varela C, de La Calle H, Canton R, de Argila C, San Roman A. Heliobacter pylori infection is markedly increased in patients with autoimmune atrophic thyroiditis. J Clin Gastroenterol. 1998, 26:259–63.

Bassi V, Marino G, Iengo A, Fattoruso O, Santinelli C. Autoimmune thyroid diseases and Helicobacter pylori: The correlation is present only in Graves’s disease. World J Gastroenterol. 2012, 18(10):1093–7.

Larizza D, Calcaterra V, Martinetti M, Negrini R, De Silvestri A, Cisternino M, et al. Helicobacter pylori infection and autoimmune thyroid disease in young patients: The disadvantage of carrying the human leukocyte antigen-DRB1*0301 allele. J Clin Endocrinol Metab. 2006, 91(1):176–9.

Soveid M, Asl KH, Omrani GR. Infection by Cag A positive strains of Helicobacter pylori is associated with autoimmune thyroid disease in Iranian patients. Iran J Immunol. 2012, 9(1):48–52.

Appelmelk BENJ, Simoons-smit INA, Negrini R, Moran AP, Aspinall GO, Forte JG, et al. Potential role of molecular mimicry between Helicobacter pylori lipopolysaccharide and host Lewis blood group antigens in autoimmunity. Infection and immunity. 1996, 64(6):2031–40.

Wirth H, Yang M, Karita M, Blaser MJ. Expression of the human cell surface glycoconjugates Lewis X and Lewis Y by Helicobacter pylori isolates is related to cagA status. Infection and immunity. 1996, 64(11):4598–605.

Censini S, Lange C, Xiang ZY, Crabtree JE, Ghiara P, Borodovsky M, et al. Cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors. Proc. Natl. Acad. Sci USA. 1996, 93:14648–53.

Oghumu S, Satoskar A. The emerging role of dendritic cells in the host immune response against Helicobacter pylori. Front Microbiol. 2014, 5:1–2.

Nagayama Y, Saitoh O, McLachlan SM, Rapoport B, Kano H, Kumazawa Y. TSH receptor-adenovirus-induced Graves’ hyperthyroidism is attenuated in both interferon-gamma and interleukin-4 knockout mice; implications for the Th1/Th2 paradigm. Clin Exp Immunol. 2004, 138(3):417–22.

Park S, Kim J, TS H, JI S. The Role of Interferon-gamma and interleukin 17 between Helicobacter pylori infection and Graves ’ disease. Helicobacter. 2011, 15(6):338.

Chey WD, Wong BCY. American College of Gastroenterology guideline on the management of Helicobacter pylori infection. Am J Gastroenterol. 2007, 102(8):1808–25.



  • There are currently no refbacks.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License